Cue Biopharma Inc
Change company Symbol lookup
Select an option...
CUE Cue Biopharma Inc
INDI indie Semiconductor Inc
JCI Johnson Controls International PLC
FPAY FlexShopper Inc
TCS Container Store Group Inc
CMSA CMS Energy Corp
LULU Lululemon Athletica Inc
MGY Magnolia Oil & Gas Corp
LGHL Lion Group Holding Ltd
C Citigroup Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a novel class of injectable biologics designed to selectively engage and modulate tumor-specific T cells within the body to treat a broad range of cancers, chronic infectious diseases, and autoimmune diseases. The Company’s proprietary Immuno-STAT (Selective Targeting and Alteration of T Cells) platform harnesses the patient’s intrinsic immune repertoire to fully exploit its potential to fight cancer and restore health while avoiding the deleterious side effects of broad immune activation. The Company’s lead product candidate from the CUE-100 series, CUE-101, is a fusion protein biologic designed to target and activate antigen-specific T cells to fight HPV-driven cancers. Its second drug product candidate, CUE-102, targets Wilms’ Tumor 1 protein (WT-1), an oncofetal antigen. It is also developing CUE-103 and its Neo-STAT and RDI-STAT programs outside of oncology.

Closing Price
$2.29
Day's Change
-0.08 (-3.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.37
Day's Low
2.27
Volume
(Light)
Volume:
164,992

10-day average volume:
231,514
164,992
  • Prev Close
    2.37
  • Today's Open
    2.37
  • Day's Range
    2.27-2.37
  • Avg Vol (10-day)
    231.5K
  • Last (time)
    4:00p ET 09/22/23
  • Last (size)
    500
  • 52-Wk Range
    2.18 - 5.12
    LowHigh
  • (10/03/22 - 05/10/23)
    5.05%
  • 77.9%
  • Market Cap
    103.0M
  • Shares Outstanding
    45.0M
  • -1.27
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.0
  • 30.33
  • (% of float 08/31/23)
    5.70

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.